Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days
Authors:
- Frederick A. BelandFBFrederick A. Beland
- Ofelia A. OliveroOOOfelia A. Olivero
- Miriam C. PoirierMPMiriam C. Poirier
Open Access
- 24 July 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 33 (11) , 2236-2241
Abstract
We have evaluated DNA damage (DNA adduct formation) after feeding benzo[a]pyrene (BP) to wild-type (WT) and cancer-susceptible Xpa(−/−)p53(+/−) mice deficient in nucleotide excision repair and haploinsufficient for the tumor suppressor p53. DNA damage was evaluated by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ES-MS/MS), which measures r7,t8,t9-trihydroxy-c-10-(N 2-deoxyguanosyl)-7,8,9,10-tetrahydrobenzo[a]pyrene (BPdG), and a chemiluminescence immunoassay (CIA), using anti-r7,t8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE)–DNA antiserum, which measures both BPdG and the other stable BP-DNA adducts. When mice were fed 100 ppm BP for 28 days, BP-induced DNA damage measured in esophagus, liver and lung was typically higher in Xpa(−/−)p53(+/−) mice, compared with WT mice. This result is consistent with the previously observed tumor susceptibility of Xpa(−/−)p53(+/−) mice. BPdG, the major DNA adduct associated with tumorigenicity, was the primary DNA adduct formed in esophagus (a target tissue in the mouse), whereas total BP-DNA adducts predominated in higher levels in the liver (a non-target tissue in the mouse). In an attempt to lower BP-induced DNA damage, we fed the WT and Xpa(−/−)p53(+/−) mice 0.3% chlorophyllin (CHL) in the BP-containing diet for 28 days. The addition of CHL resulted in an increase of BP–DNA adducts in esophagus, liver and lung of WT mice, a lowering of BPdG in esophagi of WT mice and livers of Xpa(−/−)p53(+/−) mice and an increase of BPdG in livers of WT mice. Therefore, the addition of CHL to a BP-containing diet showed a lack of consistent chemoprotective effect, indicating that oral CHL administration may not reduce PAH–DNA adduct levels consistently in human organs.Keywords
This publication has 47 references indexed in Scilit:
- Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor studyFood and Chemical Toxicology, 2012
- CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllinCancer Letters, 2010
- The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancerBiochemical and Biophysical Research Communications, 2010
- Oral benzo[a]pyrene‐induced cancer: Two distinct types in different target organs depend on the mouseCyp1genotypeInternational Journal of Cancer, 2010
- Identifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesisCarcinogenesis, 2008
- Increased genomic instability is not a prerequisite for shortened lifespan in DNA repair deficient miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A geneNature, 1995
- Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPANature, 1995
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placentaChemical Research in Toxicology, 1989